Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker IMDX
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Sep 21, 2026 | IMDX Insight Molecular Diagnostics Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Aug 10, 2026 | IMDX Insight Molecular Diagnostics Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Aug 10, 2026 | IMDX Insight Molecular Diagnostics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 10, 2026 | IMDX Insight Molecular Diagnostics Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 17, 2026 | IMDX Insight Molecular Diagnostics Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Jun 17, 2026 | IMDX Insight Molecular Diagnostics Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| May 13, 2026 | IMDX Insight Molecular Diagnostics Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| May 13, 2026 | IMDX Insight Molecular Diagnostics Inc. | 8.01 Other Events | 8-K/A | 8-K ↗ |
| Apr 30, 2026 | IMDX Insight Molecular Diagnostics Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Mar 26, 2026 | IMDX Insight Molecular Diagnostics Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 26, 2026 | IMDX Insight Molecular Diagnostics Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Feb 12, 2026 | IMDX Insight Molecular Diagnostics Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Feb 12, 2026 | IMDX Insight Molecular Diagnostics Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Feb 11, 2026 | IMDX Insight Molecular Diagnostics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 10, 2025 | IMDX Insight Molecular Diagnostics Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 2, 2025 | IMDX Insight Molecular Diagnostics Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Sep 19, 2025 | IMDX Insight Molecular Diagnostics Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Aug 11, 2025 | IMDX Insight Molecular Diagnostics Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jul 2, 2025 | IMDX Insight Molecular Diagnostics Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Jun 17, 2025 | IMDX Insight Molecular Diagnostics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jun 17, 2025 | IMDX Insight Molecular Diagnostics Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| May 12, 2025 | IMDX Insight Molecular Diagnostics Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 17, 2025 | IMDX Insight Molecular Diagnostics Inc. | 4.01 Changes in Registrant's Certifying Accountant | 8-K | 8-K ↗ |
| Mar 24, 2025 | IMDX Insight Molecular Diagnostics Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 10, 2025 | IMDX Insight Molecular Diagnostics Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Feb 10, 2025 | IMDX Insight Molecular Diagnostics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 10, 2025 | IMDX Insight Molecular Diagnostics Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Feb 10, 2025 | IMDX Insight Molecular Diagnostics Inc. | 1.02 Termination of a Material Definitive Agreement | 8-K | 8-K ↗ |
| Feb 10, 2025 | IMDX Insight Molecular Diagnostics Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jan 8, 2025 | IMDX Insight Molecular Diagnostics Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Nov 12, 2024 | IMDX Insight Molecular Diagnostics Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
31 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:20 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances